AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Mar 8, 2011
34931_dirs_2011-03-08_a7b09256-91a1-44bc-b021-8814549bc6b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-03-04
Reporting Person: Kolbert Jason (See Remarks)
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3